Identifying and definitional attributes
|Metadata item type:||Data Element|
|Short name:||Immunotherapy completion date|
|Definition:||The completion date of immunotherapy administered during the initial course of treatment for cancer, expressed as DDMMYYYY.|
|Data Element Concept:||Cancer treatment—immunotherapy completion date|
Value domain attributes
|Maximum character length:||8|
Data element attributes
Collection and usage attributes
|Guide for use:|
The completion date of immunotherapy treatment is the date of the last dose administered during the initial course of treatment. The initial course of treatment includes all treatments administered to the patient from diagnosis and before disease progression or recurrence.
The completion date of immunotherapy treatment is recorded regardless of whether the course of treatment is completed as intended, and regardless of the intent or timing of the immunotherapy.
A patient may undergo immunotherapy for an extended period of time.
The completion date of the immunotherapy treatment is recorded even if the agent is experimental.
Multiple entries are not permitted.
Dates of surgical, radiotherapy and other systemic treatments are collected as separate items. However, if a patient receives treatment with a protocol that includes different types of systemic therapy agents, for example, a chemotherapy agent and an immunotherapy agent, record the completion date of treatment in both relevant data items.
The information should be obtained from the patient’s medical record.
|Comments:||Collecting the start and finish dates for treatment modalities will enable an estimate of treatment duration.|
Source and reference attributes
|Submitting organisation:||Cancer Australia|
|Origin:||Commission on Cancer, American College of Surgeons|
American College of Surgeons 2002. Facility Oncology Registry Data Standards (FORDS), 2009 revision. Commission on Cancer
American College of Surgeons 1998. Standards of the Commission on Cancer: Registry Operations and Data Standards (ROADS), Volume II. Commission on Cancer
Johnson CH & Adamo M (Editors) 2007. SEER Program Coding and Staging Manual 2007, MD 2008 revision. Bethesda:National Cancer Institute, NIH Publication number 07-5581
|Related metadata references:|
Has been superseded by Cancer treatment—immunotherapy completion date, DDMMYYYY
See also Cancer treatment—immunotherapy agent name, systemic therapy agent or protocol name, text X[X(149)]
See also Cancer treatment—immunotherapy start date, DDMMYYYY
See also Cancer treatment—systemic therapy agent or protocol, text X[X(149)]
|Implementation in Data Set Specifications:|